Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma
暂无分享,去创建一个
Xiaowei Zhan | K. Murphy | Richard C. Wang | C. Lewis | Jiwoong Kim | Eunice E. Lee | B. Chamseddin | Rong Yang | S. Hammer | G. Hosler | R. Yang
[1] Xiaowei Zhan,et al. Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus , 2019, Nature Communications.
[2] S. Dhanasekaran,et al. The Landscape of Circular RNA in Cancer , 2019, Cell.
[3] Alain Bergeron,et al. Widespread and Functional RNA Circularization in Localized Prostate Cancer , 2019, Cell.
[4] Zhenguo Shi,et al. CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2 , 2018, Cell cycle.
[5] E. Tartour,et al. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas. , 2018, Human pathology.
[6] R. Deberardinis,et al. Differential Glucose Requirement in Skin Homeostasis and Injury Identifies a Therapeutic Target for Psoriasis , 2018, Nature Medicine.
[7] Shenglin Huang,et al. Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer. , 2018, Cancer letters.
[8] C. Rödel,et al. Anal squamous cell carcinoma - State of the art management and future perspectives. , 2018, Cancer treatment reviews.
[9] T. Robinson,et al. A National-Level Validation of the New American Joint Committee on Cancer 8th Edition Subclassification of Stage IIA and B Anal Squamous Cell Cancer , 2018, Annals of Surgical Oncology.
[10] C. Rödel,et al. Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] E. Siegel,et al. Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer , 2016, American journal of clinical oncology.
[12] L. Bullinger,et al. Circular RNAs in Cancer. , 2018, Advances in experimental medicine and biology.
[13] C. Rödel,et al. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[14] K. Emancipator,et al. Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] Yu Zhou,et al. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis , 2017, Oncotarget.
[16] Binbin Xie,et al. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis , 2017, Oncotarget.
[17] C. Rödel,et al. Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy , 2017, Oncoimmunology.
[18] J. Taube,et al. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.
[19] W. Ge,et al. HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a , 2016, Tumor Biology.
[20] R. Wirtz,et al. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy , 2015, International journal of cancer.
[21] M. Poljak,et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide , 2015, International journal of cancer.
[22] S. Steele,et al. Anal squamous cell carcinoma: an evolution in disease and management. , 2014, World journal of gastroenterology.
[23] V. Guttikonda,et al. Glut-1 as a prognostic biomarker in oral squamous cell carcinoma , 2014, Journal of oral and maxillofacial pathology : JOMFP.
[24] L. Mazzucchelli,et al. EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer. , 2014, Histology and histopathology.
[25] R. Kimple,et al. Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck. , 2014, International journal of radiation oncology, biology, physics.
[26] J. Feliu,et al. Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma , 2014, Cancer.
[27] J. Pignon,et al. Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] J. Ledermann,et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. , 2013, The Lancet. Oncology.
[29] L. Szablewski. Expression of glucose transporters in cancers. , 2013, Biochimica et biophysica acta.
[30] Alison P. Klein,et al. Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape , 2012, Science Translational Medicine.
[31] Cary A Moody,et al. Human papillomavirus oncoproteins: pathways to transformation , 2010, Nature Reviews Cancer.
[32] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[33] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[34] Charles R. Thomas,et al. Squamous cell carcinoma of the anal canal. , 2005, Surgical oncology.
[35] A. Allal,et al. Differential expression of anti-apoptotic protein Bcl-2 in keratinizing versus non-keratinizing squamous cell carcinoma of the anus , 2005, International Journal of Colorectal Disease.
[36] J. Hilden,et al. Anal cancer subtype reproducibility study , 2000, Virchows Archiv.
[37] H. Adami,et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. , 1999, Cancer research.
[38] R. Coates,et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. , 1987, The New England journal of medicine.